Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register

Supplying Medicines and Supplements to Guatemala

A practical guide for Guatemalan distributors, importers and hospital buyers who source from abroad, and for manufacturers and exporters worldwide selling into Guatemala.

This page in other languages: English · Español

Guatemala is Central America's most populous country, and one of the quickest places to register a product the FDA or EMA has already approved: under technical standard NT-77, it can get a registration number within 10 business days.

For everything else, plan for a wait. Consultants reported a backlog of over 21,000 files in 2025, with new registrations taking six to eight months. Guatemala also applies the common Central American technical regulation, so a product registered in a neighbouring country can be recognised, typically in three to four months.

Guatemala at a glance

RegulatorMinistry of Public Health and Social Assistance (MSPAS), through its department for pharmaceutical and related products
Who importsA licensed distributor with a technical director; the manufacturer, technical director and legal representative share responsibility
Fast routeProducts approved by the FDA or EMA: a registration number within 10 business days under NT-77
Standard routeSix to eight months for new registrations in 2025, or three to four months by Central American mutual recognition
Public buyersThe social security institute IGSS, plus COMISCA joint negotiations for the region

How to supply medicines to Guatemala

  1. Choose a licensed distributor. A Guatemalan distributor with a technical director imports the product and shares responsibility with the manufacturer and the legal representative.
  2. Pick the route. FDA or EMA approval opens the 10-day NT-77 route. A registration in another Central American country can be recognised. Otherwise, use the standard route.
  3. Prepare the dossier. A CTD dossier with a CoPP and the plant's GMP evidence.
  4. Supply. Private distributors and pharmacies, or tenders by IGSS, which a 2025 court order pushed towards more open competition. COMISCA's joint negotiation covers the region's health ministries and social security institutes.

The import rules list exceptions for personal use with a prescription, donations, clinical trials and special cases. See named-patient and special import and government tender supply.

Supplements

Supplements are registered with the Ministry of Health, either as foods or with the pharmaceutical department, depending on ingredients and claims. Confirm the route before you print labels. We help brands get supplements made under their own label by GMP-certified contract manufacturers: see nutraceutical private label.

What people in Guatemala search for

Semrush data from October 2026 shows that people in Guatemala search most for vitamin D and for vitamins in general (about 9,900 searches a month each), then vitamin C, protein and creatine (6,600 each). Among medicines, dexketoprofen, ceftriaxone, etoricoxib, dexamethasone and amoxicillin lead.

Guatemalans search in Spanish: “vitamina D” gets about 9,900 searches a month, “vitamina C”, “proteínas” and “creatina” 6,600 each, “colágeno hidrolizado” 4,400 and “creatina monohidratada” 3,600 (Semrush, October 2026). Medicines are typed by their Spanish generic name, led by “dexketoprofeno” (about 18,000 a month), “ceftriaxona” (13,310), “dexametasona” (12,170), “amoxicilina” (12,100) and “ciprofloxacino” (11,980).

How importers and distributors in Guatemala search

Across seven Central American and Caribbean markets combined, Guatemala among them, Google Keyword Planner shows “droguería” between 1,000 and 10,000 monthly searches, and “droguerías en Guatemala”, “laboratorios farmacéuticos en Guatemala” and “distribuidora de medicamentos” between 100 and 1,000. Semrush also picks up “proveedor médico” locally, at about 30 a month.

Originator brands searched by name include Lasix (furosemide), Nexium (esomeprazole), Forxiga (dapagliflozin), Xarelto (rivaroxaban), Concor (bisoprolol) and Plavix (clopidogrel). Brand names are trademarks of their owners and are used only to identify the medicine.

Supplements we can help you make

The most searched medicines include dexketoprofen (dexketoprofeno, about 18,000 a month), ceftriaxone, etoricoxib, dexamethasone, amoxicillin and ciprofloxacin. Some examples we list:

Documents to ask your supplier for

Not sure a supplier is genuine? Read how to verify a pharmaceutical supplier. For the neighbouring markets, see our Latin America and Caribbean import guide.

Sourcing for Guatemala?

Send the product, strength, quantity and the documents your regulator needs. We will match you with GMP-certified manufacturers and suppliers who can serve your market, wherever they are based.

Send your requirement Talk to our team

Frequently asked questions

The Ministry of Public Health and Social Assistance (MSPAS), through its department for the regulation and control of pharmaceutical and related products.

Products approved by the FDA or EMA can get a registration number within 10 business days under technical standard NT-77. Consultants reported new registrations taking six to eight months in 2025, and mutual recognition three to four.

Yes. Guatemala applies the common Central American technical regulation, and a product registered in one member state can be recognised in another.

A licensed distributor with a technical director. The manufacturer, the technical director and the legal representative share responsibility.

The social security institute IGSS. COMISCA also runs a joint price negotiation for the region's health ministries and social security institutes.

Articles and guides for Guatemala

Pharmaceutical Registration in Guatemala: DRCPFA, the RTCA Framework and Mutual Recognition

Registering medicines in Guatemala through the DRCPFA at MSPAS — the harmonised Central American RTCA dossier, mutual re...

Read Full Story

Guatemala • Pharmaceutical Registration & Regulatory Pathway

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us